Angiogenesis monitored by perfusion with a space-filling microbead suspension.
Numerous laboratories are focusing efforts on delivering gene products to induce or prevent the development of new blood vessels in adults, with the hope of rescuing ischemic tissues, circumventing cardiac bypass surgery, or inhibiting tumor growth. Current approaches to the assessment of vascular continuity involve the introduction of either dyes or fluorescent microspheres to track blood flow. However, dyes and dextrans are subject to leakage when vessels are hyperpermeable, a situation that may occur in studies of tumor vasculature and during efforts to stimulate therapeutic angiogenesis. Furthermore, the microspheres that are used for flow studies do not allow a comprehensive visual analysis of vascular continuity. Here we report a method for the visual assessment of microvascular continuity in mouse muscle under circumstances in which vessels are leaky. The approach involves perfusion of the vasculature with fluorescent beads that are much smaller than those used for flow studies. The suspension behaves like a fluid and completely fills the vessels, yet the beads do not leak from VEGF-permeablized capillaries and remain localized in histological sections. Use of beads with the proper fluorescence emission wavelengths allows immunofluorescent colocalization with vessel-specific markers. We compare this improved method with other methods for tracking vascular continuity involving dextrans and larger beads. This approach should aid in the dynamic study of tumor angiogenesis and the evaluation of efforts to deliver angiogenic factors.
Department of Molecular Pharmacology, Stanford University School of Medicine, California 94305-5332, USA.
M L
ML
Springer
T K
TK
Ip
H M
HM
Blau
D000818:Animals; D016228:Endothelial Growth Factors / Q000235:genetics; D005456:Fluorescent Dyes; D015316:Genetic Therapy; D008222:Lymphokines / Q000235:genetics; D008297:Male; D051379:Mice; D016513:Mice, SCID; D008863:Microspheres; D018482:Muscle, Skeletal / Q000098:blood supply; D009389:Neovascularization, Pathologic; D018919:Neovascularization, Physiologic; D010316:Particle Size; D010477:Perfusion; D012235:Rhodamines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D005456:Fluorescent Dyes; D008222:Lymphokines; D012235:Rhodamines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; C005358:tetramethylrhodamine